ROSIE (Riber Oxide Silicon Epitaxy)

Search documents
RIBER reaffirms its strategic roadmap at the Annual General Meeting held on June 18, 2025
Globenewswire· 2025-06-18 15:45
Core Insights - RIBER reaffirms its strategic roadmap during the Annual General Meeting, emphasizing a culture of excellence, continuous innovation, and strong customer focus to position itself at the forefront of the semiconductor industry's transformations, particularly in silicon-based integrated photonics [1][4]. Group 1: Strategic Developments - RIBER introduced ROSIE (Riber Oxide Silicon Epitaxy), an advanced platform for oxide growth on 300 mm wafers, which is fully compatible with SEMI standards, marking a significant technological breakthrough [2]. - The industrialization phase of ROSIE has commenced following a strategic partnership with the Novo Nordisk Foundation Quantum Computing Programme, which includes the qualification of the ROSIE process and the sale of the first unit scheduled for the second half of 2025 [2][3]. Group 2: Financial and Operational Highlights - The Annual General Meeting approved the statutory and consolidated financial statements for the 2024 financial year, along with a cash payout of €0.08 per share, with the ex-dividend date set for June 23, 2025 [6]. - RIBER's strategic positioning is strengthened by solid commercial momentum for its MBE equipment and the industrial rollout of ROSIE, enhancing growth and diversification potential in the semiconductor sector [4]. Group 3: Market Focus - RIBER targets several fast-growing markets, including ultra-fast optical communications, optical computing, and photonic quantum technologies, reflecting its commitment to innovation in the semiconductor industry [7]. - The company plays a crucial role in the development of advanced semiconductors used in various applications, from information technologies to 5G telecommunications networks and quantum computing [8].